OrthoPediatrics (KIDS) Competitors

$18.37 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$18.38 +0.00 (+0.03%)

As of 05/22/2026 04:10 PM Eastern

KIDS vs. PLSE, PRCT, ENOV, EYE, and CDRE

Should you buy OrthoPediatrics stock or one of its competitors? MarketBeat compares OrthoPediatrics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OrthoPediatrics include Pulse Biosciences (PLSE), PROCEPT BioRobotics (PRCT), Enovis (ENOV), National Vision (EYE), and Cadre (CDRE). These companies are all part of the "medical equipment" industry.

How does OrthoPediatrics compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

Pulse Biosciences currently has a consensus price target of $30.00, suggesting a potential upside of 15.87%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 33.07%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

77.0% of Pulse Biosciences shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 74.0% of Pulse Biosciences shares are owned by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, OrthoPediatrics had 1 more articles in the media than Pulse Biosciences. MarketBeat recorded 1 mentions for OrthoPediatrics and 0 mentions for Pulse Biosciences. OrthoPediatrics' average media sentiment score of 1.17 beat Pulse Biosciences' score of 0.00 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Overall Sentiment
Pulse Biosciences	Neutral
OrthoPediatrics	Positive

Pulse Biosciences has a net margin of 0.00% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	N/A	-86.67%	-73.61%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

OrthoPediatrics has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$350K	5,119.56	-$72.78M	-$1.10	N/A
OrthoPediatrics	$236.35M	2.00	-$39.65M	-$1.68	N/A

Pulse Biosciences has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Summary

OrthoPediatrics beats Pulse Biosciences on 11 of the 17 factors compared between the two stocks.

How does OrthoPediatrics compare to PROCEPT BioRobotics?

PROCEPT BioRobotics (NASDAQ:PRCT) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

OrthoPediatrics has a net margin of -16.31% compared to PROCEPT BioRobotics' net margin of -31.82%. OrthoPediatrics' return on equity of -7.01% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-31.82%	-27.70%	-20.29%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

OrthoPediatrics has lower revenue, but higher earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	5.36	-$95.57M	-$1.82	N/A
OrthoPediatrics	$236.35M	2.00	-$39.65M	-$1.68	N/A

PROCEPT BioRobotics has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

PROCEPT BioRobotics presently has a consensus price target of $41.45, suggesting a potential upside of 42.95%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 33.07%. Given PROCEPT BioRobotics' higher possible upside, equities analysts clearly believe PROCEPT BioRobotics is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.43
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

In the previous week, PROCEPT BioRobotics had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 3 mentions for PROCEPT BioRobotics and 1 mentions for OrthoPediatrics. PROCEPT BioRobotics' average media sentiment score of 1.25 beat OrthoPediatrics' score of 1.17 indicating that PROCEPT BioRobotics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.5% of PROCEPT BioRobotics shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 6.6% of PROCEPT BioRobotics shares are held by insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

OrthoPediatrics beats PROCEPT BioRobotics on 10 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to Enovis?

OrthoPediatrics (NASDAQ:KIDS) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

In the previous week, Enovis had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 2 mentions for Enovis and 1 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.17 beat Enovis' score of 0.67 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enovis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 98.5% of Enovis shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by insiders. Comparatively, 2.9% of Enovis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

OrthoPediatrics has a net margin of -16.31% compared to Enovis' net margin of -49.92%. Enovis' return on equity of 10.32% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Enovis	-49.92%	10.32%	4.57%

OrthoPediatrics has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, Enovis has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

OrthoPediatrics presently has a consensus price target of $24.44, suggesting a potential upside of 33.07%. Enovis has a consensus price target of $44.50, suggesting a potential upside of 84.22%. Given Enovis' stronger consensus rating and higher probable upside, analysts plainly believe Enovis is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Enovis	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89

OrthoPediatrics has higher earnings, but lower revenue than Enovis. OrthoPediatrics is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.00	-$39.65M	-$1.68	N/A
Enovis	$2.25B	0.62	-$1.18B	-$19.88	N/A

Summary

Enovis beats OrthoPediatrics on 9 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to National Vision?

National Vision (NASDAQ:EYE) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

National Vision has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.69	$29.60M	$0.57	30.05
OrthoPediatrics	$236.35M	2.00	-$39.65M	-$1.68	N/A

National Vision currently has a consensus price target of $30.08, suggesting a potential upside of 75.62%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 33.07%. Given National Vision's higher probable upside, research analysts plainly believe National Vision is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

In the previous week, National Vision had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 3 mentions for National Vision and 1 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.17 beat National Vision's score of 0.77 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

National Vision has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market.

National Vision has a net margin of 2.31% compared to OrthoPediatrics' net margin of -16.31%. National Vision's return on equity of 6.41% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

69.1% of OrthoPediatrics shares are held by institutional investors. 2.4% of National Vision shares are held by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

National Vision beats OrthoPediatrics on 10 of the 17 factors compared between the two stocks.

How does OrthoPediatrics compare to Cadre?

Cadre (NYSE:CDRE) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

44.0% of Cadre shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 30.1% of Cadre shares are owned by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cadre has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cadre	$610.31M	2.13	$44.14M	$0.89	34.11
OrthoPediatrics	$236.35M	2.00	-$39.65M	-$1.68	N/A

Cadre presently has a consensus target price of $39.75, indicating a potential upside of 30.93%. OrthoPediatrics has a consensus target price of $24.44, indicating a potential upside of 33.07%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Cadre.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cadre	2 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.43
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

Cadre has a net margin of 5.80% compared to OrthoPediatrics' net margin of -16.31%. Cadre's return on equity of 12.39% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cadre	5.80%	12.39%	5.08%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

Cadre has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

In the previous week, Cadre and Cadre both had 1 articles in the media. OrthoPediatrics' average media sentiment score of 1.17 beat Cadre's score of 0.00 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cadre	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cadre beats OrthoPediatrics on 9 of the 15 factors compared between the two stocks.

Get OrthoPediatrics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KIDS vs. The Competition

Export

Metric	OrthoPediatrics	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$471.83M	$7.10B	$6.46B	$12.34B
Dividend Yield	N/A	1.68%	2.76%	5.28%
P/E Ratio	-10.93	47.45	21.22	25.65
Price / Sales	2.00	73.72	553.92	86.28
Price / Cash	110.47	24.91	43.49	56.67
Price / Book	1.39	6.53	10.37	7.14
Net Income	-$39.65M	$158.81M	$3.57B	$335.98M
7 Day Performance	0.77%	3.61%	6.40%	4.15%
1 Month Performance	13.47%	0.74%	3.52%	2.54%
1 Year Performance	-11.81%	3.17%	34.02%	35.05%

OrthoPediatrics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KIDS OrthoPediatrics	3.6737 of 5 stars	$18.37 flat	$24.44 +33.1%	-11.8%	$471.83M	$236.35M	N/A	200	Positive News
PLSE Pulse Biosciences	1.5356 of 5 stars	$24.95 -2.6%	$30.00 +20.2%	+53.3%	$1.77B	$350K	N/A	140
PRCT PROCEPT BioRobotics	3.7742 of 5 stars	$25.91 -0.4%	$41.45 +60.0%	-49.5%	$1.48B	$308.05M	N/A	430
ENOV Enovis	4.2158 of 5 stars	$25.72 +1.9%	$45.17 +75.6%	-23.6%	$1.45B	$2.25B	N/A	7,802
EYE National Vision	4.4644 of 5 stars	$16.92 -2.3%	$30.08 +77.8%	-9.1%	$1.39B	$1.99B	29.68	13,138

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KIDS) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OrthoPediatrics (KIDS) Competitors

KIDS vs. PLSE, PRCT, ENOV, EYE, and CDRE

How does OrthoPediatrics compare to Pulse Biosciences?

Summary

How does OrthoPediatrics compare to PROCEPT BioRobotics?

Summary

How does OrthoPediatrics compare to Enovis?

Summary

How does OrthoPediatrics compare to National Vision?

Summary

How does OrthoPediatrics compare to Cadre?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OrthoPediatrics (KIDS) Competitors

KIDS vs. PLSE, PRCT, ENOV, EYE, and CDRE

How does OrthoPediatrics compare to Pulse Biosciences?

Do analysts prefer PLSE or KIDS?

Do insiders and institutionals hold more shares of PLSE or KIDS?

Does the media refer more to PLSE or KIDS?

Is PLSE or KIDS more profitable?

Which has preferable earnings and valuation, PLSE or KIDS?

Which has more risk and volatility, PLSE or KIDS?

Summary

How does OrthoPediatrics compare to PROCEPT BioRobotics?

Is PRCT or KIDS more profitable?

Which has stronger earnings & valuation, PRCT or KIDS?

Which has more volatility & risk, PRCT or KIDS?

Do analysts prefer PRCT or KIDS?

Does the media favor PRCT or KIDS?

Do insiders and institutionals have more ownership in PRCT or KIDS?

Summary

How does OrthoPediatrics compare to Enovis?

Does the media prefer KIDS or ENOV?

Do institutionals & insiders hold more shares of KIDS or ENOV?

Is KIDS or ENOV more profitable?

Which has more volatility and risk, KIDS or ENOV?

Do analysts prefer KIDS or ENOV?

Which has better valuation and earnings, KIDS or ENOV?

Summary

How does OrthoPediatrics compare to National Vision?

Which has stronger earnings & valuation, EYE or KIDS?

Do analysts recommend EYE or KIDS?

Does the media refer more to EYE or KIDS?

Which has more risk & volatility, EYE or KIDS?

Is EYE or KIDS more profitable?

Do insiders and institutionals believe in EYE or KIDS?

Summary

How does OrthoPediatrics compare to Cadre?

Do insiders & institutionals have more ownership in CDRE or KIDS?

Which has higher earnings & valuation, CDRE or KIDS?

Do analysts recommend CDRE or KIDS?

Is CDRE or KIDS more profitable?

Which has more risk and volatility, CDRE or KIDS?

Does the media refer more to CDRE or KIDS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools